T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$2.03B |
| 2 |
DuPont de Nemours
DD
|
+$1.83B |
| 3 |
Crown Castle
CCI
|
+$1.58B |
| 4 |
Microsoft
MSFT
|
+$1.48B |
| 5 |
TransUnion
TRU
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$1.72B |
| 2 |
Starbucks
SBUX
|
+$1.59B |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$1.3B |
| 4 |
Lowe's Companies
LOW
|
+$1.13B |
| 5 |
Philip Morris
PM
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.53% |
| 3 | Technology | 15% |
| 4 | Consumer Discretionary | 13.37% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XLNX
51
DELISTED
Xilinx Inc
XLNX
| $2.43B | 0.41% |
34,276,963
+8,090,177
| +31% | +$529M |
|
52
Honeywell
HON
$77B
| $2.38B | 0.41% |
18,580,879
+1,509,374
| +9% | +$187M |
|
53
Thermo Fisher Scientific
TMO
$222B
| $2.33B | 0.4% |
12,332,147
-573,884
| -4% | -$104M |
|
54
Fortive
FTV
$18.6B
| $2.3B | 0.39% |
51,602,923
+3,816,250
| +8% | +$159M |
|
55
Home Depot
HD
$350B
| $2.28B | 0.39% |
13,942,005
-6,313,013
| -31% | -$968M |
|
|
56
Gen Digital
GEN
$17.5B
| $2.28B | 0.39% |
69,479,978
+66,662,189
| +2,366% | +$2.03B |
|
57
Humana
HUM
$46.3B
| $2.28B | 0.39% |
9,339,641
-2,353,932
| -20% | -$577M |
|
58
ServiceNow
NOW
$132B
| $2.26B | 0.39% |
96,318,920
-6,569,175
| -6% | -$146M |
|
59
Johnson Controls International
JCI
$91.3B
| $2.24B | 0.38% |
55,664,850
+2,866,595
| +5% | +$116M |
|
60
Pfizer
PFE
$154B
| $2.22B | 0.38% |
65,506,723
+2,650,543
| +4% | +$85.2M |
|
|
RHT
61
DELISTED
Red Hat Inc
RHT
| $2.19B | 0.37% |
19,754,942
-3,987,516
| -17% | -$408M |
|
62
Dollar General
DG
$27B
| $2.16B | 0.37% |
26,626,867
-2,671,430
| -9% | -$200M |
|
|
WCN
63
Waste Connections
WCN
$41.9B
| $2.1B | 0.36% |
30,085,958
+2,718,726
| +10% | +$180M |
|
|
64
DuPont de Nemours
DD
$19.1B
| $2.07B | 0.35% |
11,818,030
+10,995,420
| +1,337% | +$1.83B |
|
65
Ball Corp
BALL
$16.6B
| $2.05B | 0.35% |
49,583,425
-954,862
| -2% | -$39.2M |
|
66
Marriott International
MAR
$90.9B
| $2.02B | 0.35% |
18,334,069
+417,912
| +2% | +$43.1M |
|
|
FITB
67
Fifth Third Bancorp
FITB
$51.8B
| $2B | 0.34% |
71,429,707
+11,353,084
| +19% | +$301M |
|
68
Medtronic
MDT
$114B
| $1.95B | 0.33% |
25,018,045
+961,217
| +4% | +$79.8M |
|
69
L3Harris
LHX
$54B
| $1.88B | 0.32% |
14,283,241
+693,580
| +5% | +$83.2M |
|
70
Cisco
CSCO
$483B
| $1.88B | 0.32% |
55,814,106
-1,807,358
| -3% | -$57.5M |
|
71
Qualcomm
QCOM
$170B
| $1.88B | 0.32% |
36,203,335
+1,596,295
| +5% | +$84.4M |
|
72
Willis Towers Watson
WTW
$31.9B
| $1.87B | 0.32% |
12,153,132
-3,124,536
| -20% | -$467M |
|
73
Microchip Technology
MCHP
$44.2B
| $1.87B | 0.32% |
41,641,080
+1,693,946
| +4% | +$71M |
|
74
Zoetis
ZTS
$30.9B
| $1.86B | 0.32% |
29,243,295
-5,737,646
| -16% | -$359M |
|
75
Verizon
VZ
$195B
| $1.85B | 0.32% |
37,318,832
+4,804,992
| +15% | +$226M |
|
Similar funds
T. Rowe Price Associates's Q3 2017 Portfolio in Review
As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
- T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
- T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
- T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.
Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.